ASCO 2022 Melanoma Cancer Question & Answer

Justin Moyer, MD, from UCI Medical Center, Question and Answer Session on Melanoma Cancer


Question and Answer Session

Justin Moyers, MD - ASCO 2022 Melanoma Overview: MOASC Spotlight

Justin Moyers, MD Exit Interview

Zachary Hanson, DO - Anemia and Zinc Deficiency [2022]: MOASC Spotlight

Justin Moyer, MD- About The Author, Credentials, and Affiliations

Medical oncologist and assistant clinical professor of medicine at the University of California, Irvine School of Medicine Justin T. Moyers is board certified in medical oncology and works at the University of California, Irvine Medical Center.


His clinical practice interests include skin cancers. Melanoma is another one of his clinical (oncology) specialties. His research interests include both the creation of therapies and the first phase, as well as the application of biomarkers and genomic data to the process of patient selection. He is now serving as the ASCO (American Society of Clinical Oncology) ( Editorial Fellow for JCO Precision Oncology, and he has presented research in the areas of melanoma database research, immunotherapy predictive biomarker research, and phase 1 combinatorial trial design at ASCO, SITC, ASCO-SITC, AACR, and ESMO.


Dr. Moyers attended the University of Kansas, where he was awarded a Bachelor of Science degree in Chemistry. He then went on to earn his medical degree from the University of Kansas School of Medicine. After completing his internship in internal medicine at Providence St. Vincent Medical Center in Portland, Oregon, he went on to do a fellowship in hematology and clinical oncology at Loma Linda University Medical Center in Loma Linda, California. Last but not least, he finished a fellowship at the University of Texas MD Anderson Cancer Center in Houston, Texas. The fellowship was in the Department of Investigational Cancer Therapeutics (in clinical oncology).